Subsequent Events (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 29, 2022 |
Apr. 27, 2022 |
Mar. 01, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of salary | 2.00% | ||||
| Accrued amounts (in Dollars) | $ 15,000,000 | ||||
| Salary reduce (in Dollars) | $ 56,250 | ||||
| Legal fees (in Dollars) | $ 250,000 | ||||
| Consultant agreement description | In addition, pursuant to the consultant’s agreement, upon acceptance of the data for the Phase 2b clinical trial for Dupuytren’s Contracture for publication, which has occurred, his monthly fee increased to £23,000, provided that £4,000 of such increase will be accrued and £19,000 of such fees will be payable monthly per the payroll practices of the Company in cash effective March 1, 2022 and until the earlier of (a) November 1, 2022 or (b) the Funding Determination Date, at which time all Accrued Amounts will be due. | ||||
| One Executives Agreement [Member] | |||||
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of reduce salary | 100.00% | ||||
| Salary reduce (in Dollars) | $ 225,000 | ||||
| Two Executives Agreement [Member] | |||||
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of reduce salary | 25.00% | ||||
| Subsequent Event [Member] | |||||
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of salary | 3.00% | ||||
| Legal fees (in Dollars) | $ 975,121 | ||||
| Reimbursement claim (in Dollars) | $ 250,000 | ||||
| Officer One [Member] | |||||
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of reduce salary | 20.00% | ||||
| Officer Two [Member] | |||||
| Subsequent Events (Details) [Line Items] | |||||
| Percentage of reduce salary | 25.00% |